← 返回

利用 IL-15 信号增强 NK 细胞介导的肿瘤免疫治疗

英文原题:Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy.

查看英文原题

Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy.

PubMed 2022/09/01(内容时间) Trends Immunol Q1 · IF 13.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

自然杀伤(NK)细胞是固有免疫系统的重要组成部分,因其抗肿瘤特性而长期受到临床关注。NK细胞免疫的几乎各个方面都受到白细胞介素-15(IL-15)的调控,IL-15是共同γ链家族的一种细胞因子。目前多项临床试验正在使用IL-15或其类似物治疗各种癌症。此外,NK细胞正在被基因修饰以产生膜结合型或分泌型IL-15。在此,我们讨论IL-15信号在NK细胞免疫中的关键作用,并提供IL-15在NK细胞治疗中的最新概述。

展开英文摘要原文

Natural killer (NK) cells, a crucial component of the innate immune system, have long been of clinical interest for their antitumor properties. Almost every aspect of NK cell immunity is regulated by interleukin-15 (IL-15), a cytokine in the common -chain family. Several current clinical trials are using IL-15 or its analogs to treat various cancers.

Moreover, NK cells are being genetically modified to produce membrane-bound or secretory IL-15.

Here, we discuss the key role of IL-15 signaling in NK cell immunity and provide an up-to-date overview of IL-15 in NK cell therapy.

论文信息

作者
Ma S、Caligiuri MA、Yu J
第一作者单位
Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA 91010, USA; Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Medical Center, Los Angeles, CA 91010, USA.United States
通讯作者单位
Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA 91010, USA; Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Medical Center, Los Angeles, CA 91010, USA; Comprehensive Cancer Center, City of Hope, Los Angeles, CA 91010, USA; Department of Immuno-Oncology, Beckman Research Institute, City of Hope, Los Angeles, CA 91010, USA. Electronic address: jiayu@coh.org.United States
文献类型
综述 · 非美国政府资助研究 · 美国 NIH 资助研究
期刊
Trends in immunology2022 Oct
原文标识
PubMed 36058806 · DOI 10.1016/j.it.2022.08.004